Literature DB >> 10583705

Postprandial lipoprotein metabolism and atherosclerosis.

F Karpe1.   

Abstract

Postprandial lipids and lipoproteins have been associated with the presence of cardiovascular disease in a large number of case-control studies. Because the metabolic perturbations around the postprandial situation is a key driving force for cholesterol flux between lipoproteins and tissues, together with the augmented generation of potentially atherogenic cholesterol-rich remnant lipoproteins, several hypotheses have been formulated to link excessive lipoproteinaemic response to fat intake with cardiovascular disease. Recent information on the regulation of lipoprotein remnant formation and its relation to atherosclerosis will enable us to test a pertinent clinical question: is there a direct relationship between repeated elevations of postprandial lipoproteins and development of atherosclerosis?

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583705     DOI: 10.1046/j.1365-2796.1999.00548.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  64 in total

1.  Fasting and post-prandial adipose tissue lipoprotein lipase and hormone-sensitive lipase in obesity and type 2 diabetes.

Authors:  G Costabile; G Annuzzi; L Di Marino; C De Natale; R Giacco; L Bozzetto; P Cipriano; C Santangelo; R Masella; A A Rivellese
Journal:  J Endocrinol Invest       Date:  2010-10-04       Impact factor: 4.256

Review 2.  Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes.

Authors:  Ann Bjørnshave; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2014-08-10

Review 3.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

4.  Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals.

Authors:  Oliver T Bruns; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Joachim Lauterwasser; Marija S Nikolic; Birgit Mollwitz; Martin Merkel; Nadja C Bigall; Sameer Sapra; Rudolph Reimer; Heinz Hohenberg; Horst Weller; Alexander Eychmüller; Gerhard Adam; Ulrike Beisiegel; Joerg Heeren
Journal:  Nat Nanotechnol       Date:  2009-01-25       Impact factor: 39.213

5.  Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test.

Authors:  Edward P Weiss; David A Fields; Bettina Mittendorfer; M A Dorien Haverkort; Samuel Klein
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

6.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

Review 7.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

8.  Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats.

Authors:  Megumi Matsumoto; Masashi Hosokawa; Noriko Matsukawa; Masahito Hagio; Aki Shinoki; Megumi Nishimukai; Kazuo Miyashita; Takaji Yajima; Hiroshi Hara
Journal:  Eur J Nutr       Date:  2009-11-04       Impact factor: 5.614

9.  Recreational football practice attenuates postprandial lipaemia in normal and overweight individuals.

Authors:  Darren J Paul; Jens Bangsbo; George P Nassis
Journal:  Eur J Appl Physiol       Date:  2017-12-06       Impact factor: 3.078

10.  Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy.

Authors:  Erdembileg Anuurad; Asha Thomas-Geevarghese; Sridevi Devaraj; Jeanine Albu; Robert Minolfo; Wafaa M El-Sadr; Guijing Lu; Wahida Karmally; Lars Berglund
Journal:  Atherosclerosis       Date:  2007-11-09       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.